Sponsored Links
| Eisai And Janssen Announce The Presentation Of DACOGEN(R) (decitabine) Data At ASCO From A Phase III Study In Patients With Acute Myeloid Leukemia |
 |
 |
 |
| Medical News - Lymphoma and Leukemia | |||
|
Eisai Inc. and Janssen, a Johnson & Johnson Company, both announced the presentation of data from the DACO-016 trial of DACOGEN® (decitabine) at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO)... Read more: Lymphoma / Leukemia / Myeloma News From Medical News Today
|